JYSB2101177 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-11-29 | | | | | view |
CXSL2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-06 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
JYSB2101058 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
JYSZ2300017 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | | | | view |
JYSB2101176 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-11-29 | | | | | view |
JYSB2101178 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-11-29 | | | | | view |
JYSB2200167 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | | | | view |
JYSB2300045 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | | | | view |
JYSB2101056 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
JYSB2200168 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | | | | view |
JYSB2300046 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | | | | view |
JYSB2101059 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
JYSZ2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | | | | view |
JYSB2200170 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | | | | view |
JYSB2300048 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | | | | view |
JYSZ2300018 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | | | | view |
JYSB2200169 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | | | | view |
JYSB2101179 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-11-29 | | | | | view |
JYSB2300047 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | | | | view |
JYSZ2300016 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | | | | view |